Overview

Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Status:
Completed
Trial end date:
2017-03-27
Target enrollment:
Participant gender:
Summary
This study is conducted to investigate whether the efficacy of single-dose triple therapy (Esomeprazole 40 mg, Tinidazole 1 g, and Levofluxacine 500 mg) for 14 days is superior to double-dose lansoprazole 30 mg, amoxicillin 1 g and clarithromycin 500 mg for 14 days in the treatment of H pylori infection.
Phase:
Phase 4
Details
Lead Sponsor:
Zahra Vahdat Shariatpanahi
Treatments:
Amoxicillin
Clarithromycin
Dexlansoprazole
Esomeprazole
Lansoprazole
Tinidazole